Reverb Therapeutics Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $12M

  • Investors
  • 7

Reverb Therapeutics General Information

Description

Developer of a cytokine therapy designed for cancer treatment and promoting targeted immune activation while limiting toxicity. The company uses bispecific antibodies to localize endogenous cytokines to immune cells in the tumor microenvironment (TME) and overcome toxicity issues of exogenously delivered cytokines, enabling cancer patients and the healthcare sector to redirect endogenous cytokines already in the body to cells of interest and treat cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 700 West Georgia Street
  • Suite 2500
  • Vancouver, British Columbia V7Y 1B3
  • Canada
Primary Industry
Other Healthcare Services
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 700 West Georgia Street
  • Suite 2500
  • Vancouver, British Columbia V7Y 1B3
  • Canada

Reverb Therapeutics Timeline

202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Reverb Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 19-Feb-2025 $12M Completed Pre-Clinical Trials
2. Seed Round 15-Nov-2023 Completed Pre-Clinical Trials
1. Accelerator/Incubator Completed Pre-Clinical Trials
To view Reverb Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Reverb Therapeutics Patents

Reverb Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12668627-B2 Cytokine-based therapies and methods Active 02-Mar-2023
US-12692305-B1 Cytokine-based therapies and methods Active 02-Mar-2023
US-12774329-B2 Cytokine-based therapies and methods Active 02-Mar-2023
US-20260347476-A1 Cytokine-based therapies and methods Pending 02-Mar-2023
AU-2024229625-A1 Cytokine-based therapies and methods, comprising mono- and bispecific non-blocking anti- cytokine antibody Pending 02-Mar-2023 C07K16/244
To view Reverb Therapeutics’s complete patent history, request access »

Reverb Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Reverb Therapeutics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
InBC Investment Corp. (InBC) Venture Capital Minority
KdT Ventures Venture Capital Minority
Seido Capital Venture Capital Minority
Amplitude Ventures Venture Capital Minority
Finchley Healthcare Ventures Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Reverb Therapeutics FAQs

  • When was Reverb Therapeutics founded?

    Reverb Therapeutics was founded in 2023.

  • Where is Reverb Therapeutics headquartered?

    Reverb Therapeutics is headquartered in Vancouver, Canada.

  • What is the size of Reverb Therapeutics?

    Reverb Therapeutics has 10 total employees.

  • What industry is Reverb Therapeutics in?

    Reverb Therapeutics’s primary industry is Other Healthcare Services.

  • Is Reverb Therapeutics a private or public company?

    Reverb Therapeutics is a Private company.

  • What is Reverb Therapeutics’s current revenue?

    The current revenue for Reverb Therapeutics is .

  • How much funding has Reverb Therapeutics raised over time?

    Reverb Therapeutics has raised $12.5M.

  • Who are Reverb Therapeutics’s investors?

    InBC Investment Corp. (InBC), KdT Ventures, Seido Capital, Amplitude Ventures, and Finchley Healthcare Ventures are 5 of 7 investors who have invested in Reverb Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process